Amploa MRI CRT-D, Quad CRT-D, Brava CRT-D, Quad CRT-D, Claria MRI CRT-D, Quad CRT-D, Compia MRI CRT-D Quad CRT-D, Viva Q
FDA premarket approval P010031/S602 · decided 2017-10-05
Approval details
- PMA number
- P010031
- Supplement
- S602
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Amploa MRI CRT-D, Quad CRT-D, Brava CRT-D, Quad CRT-D, Claria MRI CRT-D, Quad CRT-D, Compia MRI CRT-D Quad CRT-D, Viva Q
- Generic name
- Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)
- Applicant
- Medtronic Cardiac Rhythm Disease Management
- Date received
- 2017-09-07
- Decision date
- 2017-10-05
- Days to decision
- 28 days
- Decision code
- OK30
- Product code
- NIK
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Mounds View, MN
- Statement
- Implement residual moisture and ionic contamination monitoring.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.